Navigation Links
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Date:7/31/2008

laborate by developing life cycle regimes for existing drugs that will now be used at different dosing levels or, alternatively, by co-developing future CNS drugs that offer more therapeutic and commercial potential when delivered via implantable pump. Sierra's initial products will utilize off-patent drugs and are expected to enter clinical trials within the next year.

About Sierra Neuropharmaceuticals

Sierra Neuropharmaceuticals is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe CNS diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. http://www.sierraneuro.com

About HealthCare Ventures

Founded in 1985, HealthCare Ventures LLC is a leading venture capital firm with offices in Cambridge, MA and Princeton, NJ, specializing in life science industry investing. Over the past 23 years, HealthCare Ventures has raised $1.6 billion in eight funds, and has invested in a total of 93 companies to date. Notable HealthCare Ventures' investments include such companies as Avidia, Dendreon Pharmaceuticals, Human Genome Sciences, LeukoSite, MedImmune, Novazyme, OraSure, Replidyne, Inc., Shire Pharmaceuticals, Tolerx, Verenium Corporation, and Vicuron Pharmaceuticals. http://www.hcven.com

About Morgenthaler Ventures

Founded in 1968, Morgenthaler is a leading, national venture capital firm with offices in Menlo Park, CA (headquarters); Boston, MA; Cleveland, OH; and Boulder, CO; and with an investment focus on life sciences and information technology. Morgenthaler's life science investments, past a
'/>"/>

SOURCE Sierra Neuropharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NuVasive Completes Acquisition of Osteocel Biologics Business
2. Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc.
3. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
4. Accuri Cytometers Completes $13 Million Series C Financing
5. Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR)
6. Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
7. China Sun Group High-Tech Co. Completes Share Exchange to Create 100% Ownership in DLX Subsidiary
8. EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
9. Boston Scientific Completes Acquisition of CryoCor
10. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
11. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNews... have filed on November 16th, 2009 Flibanserin in ... dyskinesia in Parkinson,s,disease for orphan drug...ency,(EMEA). Levodopa-induced dyskinesia is a comp...kinson,s and a serious burden to some of those,aff...
(Date:11/19/2009)... World,s Top Gene Synthesis Co...um (IGSC) to Coordinate Best Practices in Risk Red...nt of Worldwide Gene Synthesis Capacity , ... of the world’s leading gene synthesis compa...y a common screening protocol to promote biosecuri...
(Date:11/18/2009)..., DAVIS, Calif., Nov. 18 Marron..., development and commercialization of effective a...ducts, announced that it has been named an IC20 co... oldest and largest national angel investing group...rmance leading to rewarding results for all stakeh...
(Date:11/18/2009)...HAMPAIGN, Ill. Imagine a polka-dotted postage sta...xins simply by changing colors. , As reported in...ry , Kenneth Suslick and his team at the Universit...r the general detection of toxic industrial chemic...nd works by visualizing odors. This sensor array ...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Marrone Bio Innovations Named an IC20 Company 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
... - Bruker AXS , a supplier of X-ray solutions for...BioSciences , announced on Tuesday the introductio...roduct lines. , ,The new systems were unveiled at...eeting in Florence, Italy. , ,Axiom 200, a new dig...stallography, was designed with zero detector nois...
...ness investors and government representatives have...5 that was enacted to stimulate investments in hig...e to a state Senate committee on Wednesday. For mo...mie business investment in high-growth companies ...dations: , , Increasing from $30 million to $60 mi...
.... -- The Medical College of Wisconsin has receive...nisms by which inhaled anesthetics protect the hum...d flow like those occurring during heart surgery. ...y of xenon and heart injuries. , ,Zeljko Bosnjak, ...gy and professor of physiology, is the principal i...
Other Biology Technology:Suggestions offered to foster high-growth business investment 2
(Date:11/20/2009)...T researchers are at work on many scientific and t...ation has recently provided support that totals ne...ollowing investigators under the American Recovery...ers have been awarded grants for investigation of ...ofessor of physics, will enhance the capabilities ...
(Date:11/20/2009)... highly precise measurements of plasma lipoprotein...onance spectroscopy (NMR), researchers led by Dani...vard Medical School in Boston, MA, the Framingham ...rtium in Stockholm, Sweden and Oxford, England per...le genome among 17,296 women of European ancestry ...
(Date:11/20/2009)...shington, DC Nov. 20, 2009) Scientists from the ...sections of the Naval Research Laboratory (NRL) or...t scientists on an Arctic expedition to initiate m... determine the spatial variation of sediment contr...e U.S. Coast Guard Cutter Polar Sea as a research ...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2International expedition investigates climate change, alternative fuels in Arctic 2Burger 3A Congress Must Act Now on Health Care 56696 1Fattah 3A Waiting Time is Over on Healthcare 56691 1In Letter to President TPC Highlights Foundation Grants in Health 56686 1In Letter to President TPC Highlights Foundation Grants in Health 56686 2In Letter to President TPC Highlights Foundation Grants in Health 56686 3
...tainly not free of risk. Since 2005, the poison em...nd Gttingen have registered a total of 17 patients...g capsules. The pharmacologist Dieter Mller and hi...ning in the current edition of Deutsches rzteblat... 218-22). , The authors report on a slimming pill...
...l house made of bamboo now stands in Changsha, Hun...professor at the USC Viterbi School of Engineering...Modern Bamboo, Timber and Composite Structures of ...ed the house, among the first of its kind in the w...y Xiao, a technology named by Popular Science ma...
... cancer has shown considerable promise in early cl... become resistant to current drugs. , Of 30 men w...ite phase I/II trial designed to evaluate safety, ...tate specific antigen (PSA) in their blood. Phase ...ug,s effect on survival in a large group of patien...
Other Biology News:A full-sized California-style home made of bamboo 2New medications show promise in treating drug-resistant prostate cancer 2New medications show promise in treating drug-resistant prostate cancer 3New medications show promise in treating drug-resistant prostate cancer 4
Mouse Anti-Human CRKRS Monoclonal Antibody, Unconjugated, Clone 2F6 from Abnova Corporation
...I can be used in intracellular staining of post-tr...abilize cells and to serve as an antibody diluent ...l permeabilization is a reversible process, it is ...onin during intracellular staining. Applications:...
Mouse Anti-Human PREB Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human ACTN4 Monoclonal Antibody, Unconjugated, Clone 4D10 from Abnova Corporation
Biology Products: